NLM Digital Collections

Search

Start Over Formats Text ✖Remove constraint Formats: Text Subjects Child ✖Remove constraint Subjects: Child Publication Year 2017 to 2019 ✖Remove constraint Publication Year: <span class="from" data-blrl-begin="2017">2017</span> to <span class="to" data-blrl-end="2019">2019</span>

23. E11(R1) addendum: clinical investigation of medicinal products in the pediatric population

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, April 2018
Subject(s):
Clinical Trials as Topic -- ethics
Drug Compounding -- standards
Pediatrics
Pharmaceutical Preparations
Child
Excipients
Infant
Infant, Newborn
International Cooperation
Models, Theoretical
Pharmaceutical Preparations -- administration & dosage
Taste
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

24. Anthrax: developing drugs for prophylaxis of inhalational anthrax

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, May 2018
Subject(s):
Anthrax -- drug therapy
Anthrax -- prevention & control
Antibiotic Prophylaxis
Clinical Trials as Topic
Drug Evaluation, Preclinical -- standards
Drugs, Investigational -- therapeutic use
Inhalation Exposure
Adult
Child
Endpoint Determination
Microbial Sensitivity Tests -- standards
Pediatrics
Product Surveillance, Postmarketing -- standards
Research Design
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

25. Clarification of orphan designation of drugs and biologics for pediatric subpopulations of common diseases

Publication:
Silver Spring, MD : Office of Orphan Products Development, Food and Drug Administration, July 2018
Subject(s):
Drug Approval
Orphan Drug Production
Pediatrics
Adolescent
Biological Products
Child
Clinical Trials as Topic
Colitis, Ulcerative -- drug therapy
HIV Infections -- drug therapy
Infant
Prevalence
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

26. Allergic rhinitis: developing drug products for treatment

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, September 2018
Subject(s):
Clinical Trials as Topic
Drug Evaluation
Rhinitis, Allergic -- drug therapy
Adrenal Cortex Hormones -- therapeutic use
Adult
Child
Drug Combinations
Research Design
Single-Blind Method
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

28. Pain in the nation: building a national resilience strategy : alcohol and drug misuse and suicide and the millennial generation : a devastating impact

Author(s):
Farberman, Rhea K., author
Publication:
Washington, DC : Trust for America's Health, June 2019
Subject(s):
Alcohol-Related Disorders -- epidemiology
Alcohol-Related Disorders -- mortality
Mortality -- trends
Resilience, Psychological
Substance-Related Disorders -- epidemiology
Suicide
Adult
Child
Child of Impaired Parents
Forecasting
Health Equity
Health Services Accessibility
Mental Health Services
School Health Services
State Government
Young Adult
Humans
United States

30. Health insurance coverage for people under age 65: definitions and estimates for 2015 to 2018

Publication:
[Washington, DC] : Congressional Budget Office, April 2019
Subject(s):
Insurance Coverage -- statistics & numerical data
Insurance Coverage -- trends
Insurance, Health -- statistics & numerical data
Insurance, Health -- trends
Adolescent
Adult
Child
Forecasting
Health Benefit Plans, Employee -- statistics & numerical data
Infant
Middle Aged
Private Sector
Public Sector
Humans
United States
State Children's Health Insurance Program (U.S.)